Bronchitis: Difference between revisions
Jump to navigation
Jump to search
Line 34: | Line 34: | ||
==Treatment== | ==Treatment== | ||
[[Bronchitis medical therapy|Medical therapy]] | [[Bronchitis surgery|Surgical options]] | [[Bronchitis primary prevention|Primary prevention]] | [[Bronchitis secondary prevention|Secondary prevention]] | [[Bronchitis cost-effectiveness of therapy|Financial costs]] | [[Bronchitis future or investigational therapies|Future therapies]] | [[Bronchitis medical therapy|Medical therapy]] | [[Bronchitis surgery|Surgical options]] | [[Bronchitis primary prevention|Primary prevention]] | [[Bronchitis secondary prevention|Secondary prevention]] | [[Bronchitis cost-effectiveness of therapy|Financial costs]] | [[Bronchitis future or investigational therapies|Future therapies]] | ||
==Prevention== | ==Prevention== |
Revision as of 20:52, 23 January 2012
Template:DiseaseDisorder infobox
Bronchitis Main page |
For patient information click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Historical Perspective
Pathophysiology
Epidemiology & Demographics
Risk Factors
Screening
Causes
Differentiating Bronchitis
Complications & Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory tests | Electrocardiogram | X Rays | CT | MRI Echocardiography or Ultrasound | Other images | Alternative diagnostics
Treatment
Medical therapy | Surgical options | Primary prevention | Secondary prevention | Financial costs | Future therapies
Prevention
In 1985, University of Newcastle, Australia Professor Robert Clancy developed an oral vaccine for acute bronchitis. This vaccine was commercialised four years later as Broncostat.[2]
References
External links
Online medical references:
- Bronchitis Lungs OnLine
- Acute Bronchitis FamilyDoctor.org (American Academy of Family Physicians)